Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease

S. G. Moesgaard; H. Aupperle; M. M. Rajamäki; T. Falk; C. E. Rasmussen; Nora Elisabeth Zois; Lisbeth Høier Olsen

doi:10.1016/j.rvsc.2014.10.003

Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease

S. G. Moesgaard, H. Aupperle, M. M. Rajamäki, T. Falk, C. E. Rasmussen, Nora Elisabeth Zois, Lisbeth Høier Olsen

Lifepharm

13 Citations (Scopus)

Abstract

This study investigated mitral valve and myocardial protein and gene expression of matrix metalloproteinases (MMPs), their tissue inhibitors (TIMPs) and transforming growth factor-β (TGF-β) and plasma MMP and TGF-β concentrations in age-matched dog groups euthanized due to either advanced myxomatous mitral valve disease (MMVD) or other reasons. Furthermore, echocardiographic data and lumen/area ratio were correlated with tissue and plasma levels of MMPs, TIMPs and TGF-βs. Mitral valve and myocardial gene expression of MMP2, MMP14, TGF-β1 and TGF-β2 were increased and plasma MMP9 was decreased in advanced MMVD dogs. Myocardial gene expression of TIMP2 and TIMP3 were increased in advanced MMVD. All affected markers correlated to echocardiographic parameters. Significantly narrowed lumen/area ratio was associated with increased myocardial expression of MMP2, MMP14, TIMP2 and TIMP3. No differences in tissue protein expression were recorded.MMP2, MMP14, TIMP2, TIMP3, TGF-β1 and TGF-β2 appear to play a local role in the development of advanced MMVD.

Original language	English
Journal	Research in Veterinary Science
Volume	97
Issue number	3
Pages (from-to)	560-567
Number of pages	8
ISSN	0034-5288
DOIs	https://doi.org/10.1016/j.rvsc.2014.10.003
Publication status	Published - 1 Dec 2014

Access to Document

10.1016/j.rvsc.2014.10.003

Cite this

Moesgaard, S. G., Aupperle, H., Rajamäki, M. M., Falk, T., Rasmussen, C. E., Zois, N. E., & Olsen, L. H. (2014). Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease. Research in Veterinary Science, 97(3), 560-567. https://doi.org/10.1016/j.rvsc.2014.10.003

Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease. / Moesgaard, S. G.; Aupperle, H.; Rajamäki, M. M. et al.
In: Research in Veterinary Science, Vol. 97, No. 3, 01.12.2014, p. 560-567.

Research output: Contribution to journal › Journal article › Research › peer-review

Moesgaard, SG, Aupperle, H, Rajamäki, MM, Falk, T, Rasmussen, CE, Zois, NE & Olsen, LH 2014, 'Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease', Research in Veterinary Science, vol. 97, no. 3, pp. 560-567. https://doi.org/10.1016/j.rvsc.2014.10.003

@article{3151fa536e8d425ea05e17ffbcbc6cd3,

title = "Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease",

abstract = "This study investigated mitral valve and myocardial protein and gene expression of matrix metalloproteinases (MMPs), their tissue inhibitors (TIMPs) and transforming growth factor-β (TGF-β) and plasma MMP and TGF-β concentrations in age-matched dog groups euthanized due to either advanced myxomatous mitral valve disease (MMVD) or other reasons. Furthermore, echocardiographic data and lumen/area ratio were correlated with tissue and plasma levels of MMPs, TIMPs and TGF-βs. Mitral valve and myocardial gene expression of MMP2, MMP14, TGF-β1 and TGF-β2 were increased and plasma MMP9 was decreased in advanced MMVD dogs. Myocardial gene expression of TIMP2 and TIMP3 were increased in advanced MMVD. All affected markers correlated to echocardiographic parameters. Significantly narrowed lumen/area ratio was associated with increased myocardial expression of MMP2, MMP14, TIMP2 and TIMP3. No differences in tissue protein expression were recorded.MMP2, MMP14, TIMP2, TIMP3, TGF-β1 and TGF-β2 appear to play a local role in the development of advanced MMVD.",

author = "Moesgaard, {S. G.} and H. Aupperle and Rajam{\"a}ki, {M. M.} and T. Falk and Rasmussen, {C. E.} and Zois, {Nora Elisabeth} and Olsen, {Lisbeth H{\o}ier}",

year = "2014",

month = dec,

day = "1",

doi = "10.1016/j.rvsc.2014.10.003",

language = "English",

volume = "97",

pages = "560--567",

journal = "Research in Veterinary Science",

issn = "0034-5288",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease

AU - Moesgaard, S. G.

AU - Aupperle, H.

AU - Rajamäki, M. M.

AU - Falk, T.

AU - Rasmussen, C. E.

AU - Zois, Nora Elisabeth

AU - Olsen, Lisbeth Høier

PY - 2014/12/1

Y1 - 2014/12/1

N2 - This study investigated mitral valve and myocardial protein and gene expression of matrix metalloproteinases (MMPs), their tissue inhibitors (TIMPs) and transforming growth factor-β (TGF-β) and plasma MMP and TGF-β concentrations in age-matched dog groups euthanized due to either advanced myxomatous mitral valve disease (MMVD) or other reasons. Furthermore, echocardiographic data and lumen/area ratio were correlated with tissue and plasma levels of MMPs, TIMPs and TGF-βs. Mitral valve and myocardial gene expression of MMP2, MMP14, TGF-β1 and TGF-β2 were increased and plasma MMP9 was decreased in advanced MMVD dogs. Myocardial gene expression of TIMP2 and TIMP3 were increased in advanced MMVD. All affected markers correlated to echocardiographic parameters. Significantly narrowed lumen/area ratio was associated with increased myocardial expression of MMP2, MMP14, TIMP2 and TIMP3. No differences in tissue protein expression were recorded.MMP2, MMP14, TIMP2, TIMP3, TGF-β1 and TGF-β2 appear to play a local role in the development of advanced MMVD.

AB - This study investigated mitral valve and myocardial protein and gene expression of matrix metalloproteinases (MMPs), their tissue inhibitors (TIMPs) and transforming growth factor-β (TGF-β) and plasma MMP and TGF-β concentrations in age-matched dog groups euthanized due to either advanced myxomatous mitral valve disease (MMVD) or other reasons. Furthermore, echocardiographic data and lumen/area ratio were correlated with tissue and plasma levels of MMPs, TIMPs and TGF-βs. Mitral valve and myocardial gene expression of MMP2, MMP14, TGF-β1 and TGF-β2 were increased and plasma MMP9 was decreased in advanced MMVD dogs. Myocardial gene expression of TIMP2 and TIMP3 were increased in advanced MMVD. All affected markers correlated to echocardiographic parameters. Significantly narrowed lumen/area ratio was associated with increased myocardial expression of MMP2, MMP14, TIMP2 and TIMP3. No differences in tissue protein expression were recorded.MMP2, MMP14, TIMP2, TIMP3, TGF-β1 and TGF-β2 appear to play a local role in the development of advanced MMVD.

U2 - 10.1016/j.rvsc.2014.10.003

DO - 10.1016/j.rvsc.2014.10.003

M3 - Journal article

C2 - 25458505

SN - 0034-5288

VL - 97

SP - 560

EP - 567

JO - Research in Veterinary Science

JF - Research in Veterinary Science

IS - 3

ER -

Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease

Abstract

Access to Document

Fingerprint

Cite this